Evidence map›Paper›PMID 22258246›Full record

ArticleJournal of virology2012

Antiretroviral therapy reduces the magnitude and T cell receptor repertoire diversity of HIV-specific T cell responses without changing T cell clonotype dominance.

Joseph A Conrad, Ramesh K Ramalingam, Coley B Duncan, Rita M Smith, Jie Wei, Louise Barnett, Brenna C Simons, Shelly L Lorey, Spyros A Kalams

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 35 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Longitudinal Changes in Cd4Journal of fungi (Basel, Switzerland) · 2019
    Article
  12. Article
  13. Harnessing CD8Frontiers in immunology · 2019
    Review
  14. Mechanisms of CD8European journal of immunology · 2018
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Multiparameter analysis of stimulated human peripheral blood mononuclear cells: A comparison of mass and fluorescence cytometry.Cytometry. Part A : the journal of the International Society for Analytical Cytology · 2016
    Article
  20. HIV-specific CD8⁺ T cells and HIV eradication.The Journal of clinical investigation · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Joseph A ConradDepartment of Medicine, Division of Infectious Diseases, Vanderbilt University, Nashville, Tennessee, USA.
Ramesh K Ramalingam
Coley B Duncan
Rita M Smith
Jie Wei
Louise Barnett
Brenna C Simons
Shelly L Lorey
Spyros A Kalams
Vanderbilt University · USVanderbilt University Medical Center · US

Funding

VIROLOGY COREP30AI054999 · NIAID · VANDERBILT UNIVERSITY · PI D'AQUILA, RICHARD · 2003 to 2011
$10.3M
TCR GENE USAGE AND QUANTITATION OF HIV SPECIFIC CTLR01AI039966 · NIAID · VANDERBILT UNIVERSITY · PI KALAMS, SPYROS A · 1997 to 2006
$3.2M
NIAID NIH HHS AI39966NIAID NIH HHS AI54999NIAID NIH HHS P30 AI054999NIAID NIH HHS R01 AI039966
6 · The paper itself

Abstract

After initiation of antiretroviral therapy (ART), HIV loads and frequencies of HIV epitope-specific immune responses decrease. A diverse virus-specific T cell receptor (TCR) repertoire allows the host to respond to viral epitope diversity, but the effect of antigen reduction as a result of ART on the TCR repertoire of epitope-specific CD8(+) T cell populations has not been well defined. We determined the TCR repertoires of 14 HIV-specific CD8(+) T cell responses from 8 HIV-positive individuals before and after initiation of ART. We used multiparameter flow cytometry to measure the distribution of memory T cell subsets and the surface expression of PD-1 on T cell populations and T cell clonotypes within epitope-specific responses from these individuals. Post-ART, we noted decreases in the frequency of circulating epitope-specific T cells (P = 0.02), decreases in the number of T-cell clonotypes found within epitope-specific T cell receptor repertoires (P = 0.024), and an overall reduction in the amino acid diversity within these responses (P < 0.0001). Despite this narrowing of the T cell response to HIV, the overall hierarchy of dominant T cell receptor clonotypes remained stable compared to that pre-ART. CD8(+) T cells underwent redistributions in memory phenotypes and a reduction in CD38 and PD-1 expression post-ART. Despite extensive remodeling at the structural and phenotypic levels, PD-1 was expressed at higher levels on dominant clonotypes within epitope-specific responses before and after initiation of ART. These data suggest that the antigen burden may maintain TCR diversity and that dominant clonotypes are sensitive to antigen even after dramatic reductions after initiation of ART.

Indexed as

Anti-HIV AgentsAntiretroviral Therapy, Highly ActiveEpitopes, T-LymphocyteGenetic VariationHIVHIV InfectionsHumansImmunodominant EpitopesImmunologic MemoryLymphocyte ActivationProgrammed Cell Death 1 ReceptorReceptors, Antigen, T-CellT-LymphocytesAnti-HIV AgentsEpitopes, T-LymphocyteImmunodominant EpitopesPDCD1 protein, humanProgrammed Cell Death 1 ReceptorReceptors, Antigen, T-Cell

Identifiers

PMID22258246
PMCPMC3318638
OpenAlexW2077032728

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.